Aprogen Biologics Statistics
Total Valuation
KRX:003060 has a market cap or net worth of KRW 128.82 billion. The enterprise value is 350.18 billion.
Market Cap | 128.82B |
Enterprise Value | 350.18B |
Important Dates
The next estimated earnings date is Thursday, November 13, 2025.
Earnings Date | Nov 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
KRX:003060 has 197.57 million shares outstanding. The number of shares has increased by 188.33% in one year.
Current Share Class | 197.57M |
Shares Outstanding | 197.57M |
Shares Change (YoY) | +188.33% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 0.01% |
Owned by Institutions (%) | 0.09% |
Float | 84.71M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.89 |
PB Ratio | 0.38 |
P/TBV Ratio | 0.49 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.89 |
EV / Sales | 5.13 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -6.15 |
Financial Position
The company has a current ratio of 0.64, with a Debt / Equity ratio of 0.53.
Current Ratio | 0.64 |
Quick Ratio | 0.26 |
Debt / Equity | 0.53 |
Debt / EBITDA | n/a |
Debt / FCF | -3.16 |
Interest Coverage | -11.93 |
Financial Efficiency
Return on equity (ROE) is -50.77% and return on invested capital (ROIC) is -10.44%.
Return on Equity (ROE) | -50.77% |
Return on Assets (ROA) | -9.26% |
Return on Invested Capital (ROIC) | -10.44% |
Return on Capital Employed (ROCE) | -22.01% |
Revenue Per Employee | 174.74M |
Profits Per Employee | -474.17M |
Employee Count | 391 |
Asset Turnover | 0.11 |
Inventory Turnover | 1.74 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.59% in the last 52 weeks. The beta is 0.06, so KRX:003060's price volatility has been lower than the market average.
Beta (5Y) | 0.06 |
52-Week Price Change | -50.59% |
50-Day Moving Average | 631.94 |
200-Day Moving Average | 738.05 |
Relative Strength Index (RSI) | 59.66 |
Average Volume (20 Days) | 498,559 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:003060 had revenue of KRW 68.32 billion and -185.40 billion in losses. Loss per share was -969.88.
Revenue | 68.32B |
Gross Profit | -26.77B |
Operating Income | -89.72B |
Pretax Income | -185.44B |
Net Income | -185.40B |
EBITDA | -69.52B |
EBIT | -89.72B |
Loss Per Share | -969.88 |
Balance Sheet
The company has 29.18 billion in cash and 179.80 billion in debt, giving a net cash position of -150.62 billion or -762.34 per share.
Cash & Cash Equivalents | 29.18B |
Total Debt | 179.80B |
Net Cash | -150.62B |
Net Cash Per Share | -762.34 |
Equity (Book Value) | 338.48B |
Book Value Per Share | 1,355.12 |
Working Capital | -69.46B |
Cash Flow
In the last 12 months, operating cash flow was -39.80 billion and capital expenditures -17.17 billion, giving a free cash flow of -56.97 billion.
Operating Cash Flow | -39.80B |
Capital Expenditures | -17.17B |
Free Cash Flow | -56.97B |
FCF Per Share | -288.34 |
Margins
Gross margin is -39.18%, with operating and profit margins of -131.32% and -271.36%.
Gross Margin | -39.18% |
Operating Margin | -131.32% |
Pretax Margin | -271.41% |
Profit Margin | -271.36% |
EBITDA Margin | -101.74% |
EBIT Margin | -131.32% |
FCF Margin | n/a |
Dividends & Yields
KRX:003060 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -188.33% |
Shareholder Yield | n/a |
Earnings Yield | -143.93% |
FCF Yield | -44.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on March 27, 2024. It was a reverse split with a ratio of 0.1.
Last Split Date | Mar 27, 2024 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
KRX:003060 has an Altman Z-Score of -0.96 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.96 |
Piotroski F-Score | 1 |